https://www.fiercebiotech.com/medical-devices/endotronix-raises-32m-series-c-for-heart-failure-management
Endotronix raises $32M Series C for heart failure management | Fierce Biotech
Jul 14, 2016 - Digital health company Endotronix closed a $32 million Series C, which will go toward developing and commercializing its heart failure management system.
heart failure managementseries craises